Popular Trials
Monoclonal Antibodies
Vedolizumab for Crohn's Disease
Recruiting4 awardsPhase 4
Saint Louis, Missouri
This trial aims to guide doctors on using vedolizumab for patients with small bowel Crohn's Disease. Vedolizumab helps reduce intestinal inflammation by blocking specific cells. The study will also explore new ways to predict and monitor long-term treatment success. Vedolizumab has been a standard treatment for inflammatory bowel diseases like Crohn's disease and ulcerative colitis.
Behavioural Intervention
Virtual Reality Therapy for Inflammatory Bowel Disease
Recruiting1 award
Ann Arbor, Michigan
This trial is investigating the use of virtual reality therapy for patients with inflammatory bowel disease who are in the hospital. The goal is to see if this type of therapy is feasible and well-received for managing
Biologic Care Pathway for Inflammatory Bowel Disease
Recruiting1 award
Halifax, Nova Scotia
This trial aims to study the use of standardized care pathways for patients with Inflammatory Bowel Disease (IBD) to improve treatment outcomes. The researchers will investigate how implementing a Biologic Care Pathway
Popular Filters
Trials for Crohn's Disease Patients
Behavioural Intervention
Cognitive Behavioral Therapy vs. Sudarshan Kriya Yoga for Depression in IBD
Recruiting1 award
New Haven, Connecticut
This trial is testing if talk therapy (CBT) or yoga breathing exercises (SKY) can help reduce anxiety and depression in people with Crohn's disease. The study will compare the effects of these treatments on mental health, quality of life, pain, and fatigue. Yoga has several mechanisms that make it a promising treatment for depression and anxiety, including physical activity, behavioural activation, and mindfulness.
Behavioral
Remote Monitoring for Inflammatory Bowel Disease
Recruiting1 award
Baltimore, Maryland
This trial will help assess whether or not a remote monitoring digital health system can improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease.
Immunomodulator Strategy for Inflammatory Bowel Disease
Recruiting1 award
La Jolla, California
This trial will compare the effectiveness of switching to a different immunomodulator drug versus continuing the same drug in patients with IBD who are in remission but have moderate to severe endoscopic inflammation.
Behavioral
Cognitive Behavioural Therapy for Inflammatory Bowel Disease
Recruiting1 award6 criteria
Winnipeg, Manitoba
This trial will compare an internet-based cognitive behavioural therapy intervention to usual care in reducing stress, anxiety, and depression for people with Inflammatory Bowel Disease and comorbid anxiety and/or depression.
Behavioural Intervention
Specialty Medical Homes for IBD and Behavioral Health Conditions
Recruiting1 award2 criteria
Pittsburgh, Pennsylvania
This trial will compare two care strategies for people with IBD and BH, including in-person and technology-supported care. Data will be collected over time through self-report, interviews, and electronic health records.
2'-FL Supplement for Inflammatory Bowel Disease
Recruiting0 awardsPhase 1 & 2
Hartford, Connecticut
This trial tests 2'-FL, a sugar from breast milk, as a dietary supplement for young IBD patients in stable remission. It aims to boost good gut bacteria and improve gut health by increasing butyrate levels. 2'-FL, a human milk oligosaccharide, has been shown to promote the growth of beneficial gut bacteria and improve gut health in various studies.
Trials for Inflammatory Bowel Disease Patients
Behavioral
Remote Monitoring for Inflammatory Bowel Disease
Recruiting1 award
Baltimore, Maryland
This trial will help assess whether or not a remote monitoring digital health system can improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease.
Behavioral
Cognitive Behavioural Therapy for Inflammatory Bowel Disease
Recruiting1 award6 criteria
Winnipeg, Manitoba
This trial will compare an internet-based cognitive behavioural therapy intervention to usual care in reducing stress, anxiety, and depression for people with Inflammatory Bowel Disease and comorbid anxiety and/or depression.
Behavioural Intervention
Specialty Medical Homes for IBD and Behavioral Health Conditions
Recruiting1 award2 criteria
Pittsburgh, Pennsylvania
This trial will compare two care strategies for people with IBD and BH, including in-person and technology-supported care. Data will be collected over time through self-report, interviews, and electronic health records.
2'-FL Supplement for Inflammatory Bowel Disease
Recruiting0 awardsPhase 1 & 2
Hartford, Connecticut
This trial tests 2'-FL, a sugar from breast milk, as a dietary supplement for young IBD patients in stable remission. It aims to boost good gut bacteria and improve gut health by increasing butyrate levels. 2'-FL, a human milk oligosaccharide, has been shown to promote the growth of beneficial gut bacteria and improve gut health in various studies.
Microbiome Modulator
FMT + Bezlotoxumab for IBD and C. Difficile Infection
Recruiting1 awardPhase 2
Boston, Massachusetts
This trial is testing whether FMT (fecal microbiota transplantation) plus bezlotoxumab is better than FMT plus placebo for treating IBD (inflammatory bowel disease) and CDI (clostridium difficile infection). Up to 150 patients will be enrolled, and they will be followed for 3 months.
Trials With No Placebo
Behavioural Intervention
Cognitive Behavioral Therapy vs. Sudarshan Kriya Yoga for Depression in IBD
Recruiting1 award
New Haven, Connecticut
This trial is testing if talk therapy (CBT) or yoga breathing exercises (SKY) can help reduce anxiety and depression in people with Crohn's disease. The study will compare the effects of these treatments on mental health, quality of life, pain, and fatigue. Yoga has several mechanisms that make it a promising treatment for depression and anxiety, including physical activity, behavioural activation, and mindfulness.
Behavioral
Remote Monitoring for Inflammatory Bowel Disease
Recruiting1 award
Baltimore, Maryland
This trial will help assess whether or not a remote monitoring digital health system can improve adherence, clinical outcomes, and decrease healthcare utilization compared to standard care in participants with inflammatory bowel disease.
Immunomodulator Strategy for Inflammatory Bowel Disease
Recruiting1 award
La Jolla, California
This trial will compare the effectiveness of switching to a different immunomodulator drug versus continuing the same drug in patients with IBD who are in remission but have moderate to severe endoscopic inflammation.
Behavioral
Cognitive Behavioural Therapy for Inflammatory Bowel Disease
Recruiting1 award6 criteria
Winnipeg, Manitoba
This trial will compare an internet-based cognitive behavioural therapy intervention to usual care in reducing stress, anxiety, and depression for people with Inflammatory Bowel Disease and comorbid anxiety and/or depression.
Behavioural Intervention
Specialty Medical Homes for IBD and Behavioral Health Conditions
Recruiting1 award2 criteria
Pittsburgh, Pennsylvania
This trial will compare two care strategies for people with IBD and BH, including in-person and technology-supported care. Data will be collected over time through self-report, interviews, and electronic health records.
Frequently Asked Questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the 'trial drug' — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
Is there any support for travel costs?
Many of the teams running clinical trials will cover the cost of transportation to-and-from their care center.
Will I know what medication I am taking?
This depends on the specific study. If you're worried about receiving a placebo, you can actively filter out these trials using our search.
How long do clinical trials last?
Some trials will only require a single visit, while others will continue until your disease returns. It's fairly common for a trial to last somewhere between 1 and 6 months.
Do you verify all the trials on your website?
All of the trials listed on Power have been formally registered with the US Food and Drug Administration. Beyond this, some trials on Power have been formally 'verified' if the team behind the trial has completed an additional level of verification with our team.
How quickly will I hear back from a clinical trial?
Sadly, this response time can take anywhere from 6 hours to 2 weeks. We're working hard to speed up how quickly you hear back — in general, verified trials respond to patients within a few days.